TransAct Technologies Incorporated — FY2014 Form 10-K
Reporting period: Fiscal year ended December 31, 2014; filed March 30, 2015. TransAct designs and sells transaction printers, terminals, software, supplies, and related services across food safety, banking/POS, casino and gaming, lottery, and specialty printing markets. It reports one operating segment.
Financial performance and liquidity
| Metric | FY2014 | FY2013 |
|---|---|---|
| Net sales | $53.108 million | $60.141 million |
| Gross profit / margin | $21.711 million / 40.9% | $25.092 million / 41.7% |
| Operating income (loss) / margin | $(3.772) million / (7.1%) | $6.617 million / 11.0% |
| Net income (loss) | $(2.421) million; $(0.29) diluted EPS | $4.935 million; $0.57 diluted EPS |
| Cash from operating activities | $6.053 million | $2.493 million |
| Cash and cash equivalents at year-end | $3.131 million | $2.936 million |
| Working capital / current ratio | $18.361 million / 2.9 | $24.871 million / 4.4 |
| Total assets / shareholders’ equity | $35.491 million / $25.394 million | $40.408 million / $32.521 million |
| Debt outstanding | None | None |
FY2014 operating cash flow benefited from lower accounts receivable and inventory, while accounts payable declined. Capital expenditures were $0.660 million. The company returned approximately $5.190 million to shareholders through $2.634 million of repurchases and $2.556 million of dividends. The $20 million TD Bank revolving facility was undrawn at year-end and renewed through November 2017; the company reported compliance with its covenants.
Fourth-quarter 2014 sales were $12.296 million versus $12.528 million in Q4 2013; gross profit was $4.911 million versus $5.001 million. Q4 net loss was $3.040 million, or $(0.37) per diluted share, compared with net income of $1.109 million, or $0.13 per diluted share.
Changes versus the prior comparable period
- Full-year sales fell 11.7%. Casino and gaming declined 16.7% to $22.731 million, mainly reflecting weak domestic replacement demand and fewer EPICENTRAL installations. Food safety, banking and POS declined 17.6% to $9.308 million; Printrex fell 9.8% to $3.910 million; and TSG fell 2.8% to $12.398 million.
- Lottery revenue rose 7.0% to $4.761 million. International sales increased 5.6% to $14.541 million, or 27.4% of total sales; U.S. sales declined.
- Gross margin decreased 80 basis points, principally due to lower sales of higher-margin food safety terminals, casino printers, and EPICENTRAL systems.
- Operating results were heavily affected by $5.505 million of legal fees and settlement expenses, including the $3.625 million settlement charge recorded in Q4. Excluding this unusual litigation cost, the filing does not provide a single adjusted operating-income figure.
Outlook, material events, and risks
- Management expected 2015 to be “much improved,” citing cost reductions expected to lower annual expenses by at least $1 million beginning in Q1 2015, and anticipated improved gross margin from value-added products and cost initiatives. These are expectations, not reported results.
- Management expected 2015 GTECH sales to exceed 2014, especially in the first half, based on orders and forecasts. The exclusive supply agreement ran through May 8, 2015; negotiations to extend it were ongoing. GTECH accounted for 16% of FY2014 sales.
- The company expected TSG sales to be broadly consistent with 2014, lower engineering and product-development expenses, approximately $0.8 million of capital expenditures, and approximately $2.5 million of dividends in 2015. It also expected declining oil prices to continue to pressure Printrex sales.
- The Avery Dennison trade-secret litigation was settled on March 25, 2015, after year-end. TransAct agreed to pay $3.6 million by April 8, 2015 and incur an estimated $25,000 to qualify certain labels. The total $3.625 million was accrued in FY2014; the filing also anticipated about $2 million of related legal fees in Q1 2015.
- Key risks include customer and channel concentration (Eurocoin represented 11% of sales), dependence on overseas contract manufacturing and sole-source suppliers, competitive and cyclical demand, uncertain adoption of newer products, and foreign-market and currency exposure. Approximately 80% of printer manufacturing was attributed to one Asian manufacturer in the risk discussion; the business description separately states approximately 95% of production was primarily through one Asian contract manufacturer and other sources.
- Backlog was $11.356 million as of February 27, 2015, compared with $4.778 million a year earlier; the company expected to ship it during 2015. Disclosure controls and internal control over financial reporting were reported effective; the auditor issued an unqualified opinion.
Important facts for investors to verify
- Whether the GTECH agreement was extended and how customer concentration and lottery orders evolved after May 8, 2015.
- Whether the projected $1 million-plus annual savings, improved 2015 performance, and expected margin recovery were achieved.
- Actual payment and final costs associated with the Avery Dennison settlement, including Q1 2015 legal fees.
- Cash-flow quality: the extent to which FY2014 operating cash generation depended on receivables and inventory reductions and the settlement accrual.
- Production concentration and continuity arrangements with contract manufacturers and sole-source suppliers, particularly as demand and oil prices changed.